Computational AOP modeling links 1-nitropyrene exposure to asthma exacerbation and COPD progression

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Nitropyrene (1-NP), a PM2.5-bound nitro-PAH, is a high-priority air pollutant with genotoxic and inflammatory potential, but the cascade linking exposure to asthma exacerbation and COPD progression remains unclear. We developed a multiscale computational respiratory toxicology pipeline integrating network toxicology, clinical transcriptomics, machine-learning feature selection with SHAP (LASSO, SVM-RFE), immune deconvolution (CIBERSORT), single-cell validation, protein–ligand docking, 100-ns molecular dynamics with MM/PBSA, and single-cell virtual knockout (scTenifoldKnk). Outputs were synthesized into an OECD-aligned computational pathway for adverse outcome prediction (cpAOPs) using AOP-HelpFinder 3.0. Nine core targets were linked to 1-NP–associated asthma exacerbation (CTNNB1, CXCL2, CXCL3, EHD1, GPER1, IFRD1, MSR1, SLC7A5, TFRC) and five to COPD progression (TP53, EPHX1, THBS1, LTB4R, LTF). These signatures discriminated severity (asthma AUC 0.824–0.969; COPD AUC ≥ 0.70), with CTNNB1 and TP53 showing the highest SHAP contributions. Asthma severity was associated with increased CD8 + T cells, resting CD4 memory T cells and mast cells, and reduced macrophage subsets. Single-cell data showed broad expression of asthma targets across macrophage, neutrophil, endothelial and epithelial compartments, whereas COPD targets were more cell-type restricted. Docking/MD supported stable multi-target binding (MM/PBSA ΔG − 12.43 to − 47.03 kcal/mol). Virtual knockout implicated IL-17/Th differentiation and NF-κB/MAPK–cytokine signaling in asthma, and oxidative stress, p53 responses, senescence/autophagy and cytokine amplification in COPD. This OECD-consistent cpAOPs framework links 1-NP exposure to airway outcomes, providing mechanistically anchored biomarkers for severity stratification and regulatory-grade risk assessment.

Article activity feed